RCUS
Arcus Biosciences Inc
NYSE: RCUS · HEALTHCARE · BIOTECHNOLOGY
$24.13
-2.70% today
Updated 2026-04-29
Market cap
$3.03B
P/E ratio
—
P/S ratio
12.27x
EPS (TTM)
$-3.29
Dividend yield
—
52W range
$7 – $29
Volume
1.3M
Arcus Biosciences Inc (RCUS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $1.41M | $8.35M | $15.00M | $78.00M | $383.00M | $112.00M | $117.00M | $258.00M | $247.00M |
| Revenue growth (YoY) | — | — | +491.2% | +79.6% | +420.0% | +391.0% | -70.8% | +4.5% | +120.5% | -4.3% |
| Cost of revenue | $1.31M | $2.61M | $49.65M | $78.48M | $159.00M | $7.06M | $14.00M | $340.00M | $10.00M | $10.00M |
| Gross profit | $-1.31M | $1.41M | $8.35M | $15.00M | $78.00M | $383.00M | $112.00M | $117.00M | $258.00M | $237.00M |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.0% |
| R&D | $14.25M | $47.22M | $49.65M | $78.48M | $159.00M | $257.00M | $288.00M | $340.00M | $448.00M | $523.00M |
| SG&A | $3.94M | $7.64M | $13.57M | $25.23M | $43.00M | $72.00M | $104.00M | $117.00M | $120.00M | $110.00M |
| Operating income | $-18.18M | $-53.44M | $-54.86M | $-88.71M | $-124.00M | $54.00M | $-280.00M | $-340.00M | $-330.00M | $-386.00M |
| Operating margin | — | -3782.1% | -656.8% | -591.4% | -159.0% | 14.1% | -250.0% | -290.6% | -127.9% | -156.3% |
| EBITDA | $-16.87M | $-50.83M | $-51.20M | $-85.13M | $-120.00M | $59.00M | $-258.00M | $-291.00M | $-269.00M | $-335.00M |
| EBITDA margin | — | -3597.2% | -612.9% | -567.5% | -153.8% | 15.4% | -230.4% | -248.7% | -104.3% | -135.6% |
| EBIT | $-18.18M | $-53.44M | $-54.86M | $-88.71M | $-123.00M | $55.00M | $-264.00M | $-299.00M | $-279.00M | $-345.00M |
| Interest expense | $0.00 | $0.00 | $4.92M | $0.00 | $0.00 | $260000.00 | $2.00M | $2.00M | $4.00M | $8.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.97M | $-53.08M | $-49.59M | $-75.93M | $-123.00M | $53.00M | $-267.00M | $-307.00M | $-283.00M | $-353.00M |
| Net income growth (YoY) | — | -195.4% | +6.6% | -53.1% | -62.0% | +143.1% | -603.8% | -15.0% | +7.8% | -24.7% |
| Profit margin | — | -3756.7% | -593.7% | -506.2% | -157.7% | 13.8% | -238.4% | -262.4% | -109.7% | -142.9% |